China’s CanSino, Post-AstraZeneca Partnership, Pursues Additional Vaccine Contracts
CanSino Biologics, a prominent Chinese vaccine manufacturer, is actively seeking new vaccine contracts following its recent ...
Read moreCanSino Biologics, a prominent Chinese vaccine manufacturer, is actively seeking new vaccine contracts following its recent ...
Read moreSHANGHAI (CHINA) - China's CanSino Biologics Inc said on Wednesday that expert opinion on its coronavirus ...
Read moreBEIJING (CHINA) - Beijing has granted patent approval to China's vaccine specialist CanSino Biologics Inc for ...
Read more